Sandoz gets exclusive rights to commercialize biosimilar SB17 ustekinumab in US, Canada, EEA, Switzerland and UK Ruchika Sharma11 Sept 2023 1:30 PM ISTThe reference medicine Stelara (ustekinumab) is a monoclonal antibody medication to interleukin (IL)-12/23 for the treatment of autoimmune disorders...
Roche open to big acquisitions 'if it makes scientific and financial sense', CEO tells NZZ am Sonntag Ruchika Sharma11 Sept 2023 12:23 PM ISTZurich: Roche is open to making big acquisitions if they make "sense", Chief Executive Thomas Schinecker said, with the Swiss drugmaker...
Strides Pharma Science Singapore arm gets USFDA nod for Sevelamer Carbonate for Oral Suspension Ruchika Sharma11 Sept 2023 11:39 AM ISTSevelamer Carbonate for Oral Suspension is a medication used to manage elevated levels of phosphate in the blood of patients with chronic kidney...
Moderna, Immatics collaborate to develop innovative oncology therapeutics Ruchika Sharma11 Sept 2023 10:00 AM ISTCambridge: Moderna, Inc. and Immatics N.V., a clinical-stage biopharmaceutical company active in the discovery and development of T cell-redirecting...
Daiichi Sankyo DS-3939 enters clinical development in patients across several types of advanced solid cancers Ruchika Sharma10 Sept 2023 3:54 PM ISTTokyo: Daiichi Sankyo has announced that the first patient has been dosed in a first-in-human phase 1/2 trial evaluating DS-3939 in patients with...
Pfizer, Valneva report positive pediatric, adolescent phase 2 booster results for Lyme disease vaccine Ruchika Sharma10 Sept 2023 2:30 PM ISTNew York: Valneva SE and Pfizer Inc. have announced positive pediatric and adolescent immunogenicity and safety data for their Lyme...
Merck, Portage Biotech collaborate to evaluate Portage's next-generation adenosine antagonists in combination with Keytruda in solid tumors Ruchika Sharma10 Sept 2023 11:30 AM ISTWestport: Portage Biotech Inc., a clinical-stage immuno-oncology company advancing novel multi-targeted therapies for use as monotherapy and in...
Daiichi Sankyo submits sNDA for Omicron XBB.1.5-adapted COVID vaccine in Japan Ruchika Sharma10 Sept 2023 10:00 AM ISTTokyo: Daiichi Sankyo has announced that it has submitted a supplemental New Drug Application (sNDA) to Japan’s Ministry of Health, Labour and...
Alveoair spirometer earns USFDA clearance for distribution in US Ruchika Sharma9 Sept 2023 3:54 PM ISTPune: Alveofit (Roundworks Technologies Private Limited) has announced that its groundbreaking product, alveoair spirometer, has earned U.S. FDA...
Janssen declares positive topline results from Phase 3 study evaluating RYBREVANT given with, without lazertinib combined with chemotherapy versus chemotherapy alone Ruchika Sharma9 Sept 2023 1:45 PM ISTNew Jersey: The Janssen Pharmaceutical Companies of Johnson & Johnson has announced positive topline results from the three-arm Phase 3 ...
Phase 2 study of Zilebesiran met primary endpoint: Roche,Alnylam Ruchika Sharma9 Sept 2023 12:38 PM ISTBasel: Roche and Alnylam have announced that the Phase 2 study KARDIA-1 of zilebesiran, an investigational RNAi therapeutic targeting liver-expressed...
Zydus Lifesciences incorporates wholly owned subsidiary company in Canada Ruchika Sharma9 Sept 2023 10:59 AM ISTAhmedabad: Zydus Lifesciences Limited has announced that the Company has incorporated a wholly owned subsidiary company namely Zydus Pharmaceuticals...
